Grail, Inc. (NASDAQ:GRAL - Get Free Report)'s share price dropped 7.2% during trading on Monday . The company traded as low as $32.93 and last traded at $33.21. Approximately 130,828 shares changed hands during mid-day trading, a decline of 89% from the average daily volume of 1,221,822 shares. The stock had previously closed at $35.78.
Analyst Upgrades and Downgrades
GRAL has been the topic of a number of recent analyst reports. Canaccord Genuity Group began coverage on shares of Grail in a research note on Monday, April 21st. They set a "buy" rating and a $32.00 price target on the stock. Morgan Stanley upped their target price on shares of Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research report on Tuesday, March 18th.
Get Our Latest Stock Analysis on GRAL
Grail Price Performance
The business has a 50-day moving average price of $30.08 and a two-hundred day moving average price of $25.16.
Grail (NASDAQ:GRAL - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. As a group, sell-side analysts forecast that Grail, Inc. will post -15.15 EPS for the current year.
Insider Buying and Selling at Grail
In related news, CEO Robert P. Ragusa sold 7,625 shares of the company's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.21, for a total transaction of $237,976.25. Following the transaction, the chief executive officer now owns 828,662 shares of the company's stock, valued at approximately $25,862,541.02. This represents a 0.91 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Aaron Freidin sold 1,816 shares of Grail stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $56,659.20. Following the completion of the sale, the chief financial officer now directly owns 335,170 shares of the company's stock, valued at $10,457,304. The trade was a 0.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 11,550 shares of company stock worth $360,436.
Institutional Trading of Grail
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. S.A. Mason LLC boosted its position in shares of Grail by 50.1% in the first quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock worth $38,000 after acquiring an additional 500 shares during the last quarter. KBC Group NV boosted its holdings in shares of Grail by 187.7% in the 1st quarter. KBC Group NV now owns 1,430 shares of the company's stock valued at $37,000 after purchasing an additional 933 shares during the last quarter. Caldwell Sutter Capital Inc. purchased a new stake in shares of Grail during the 1st quarter valued at $28,000. Signaturefd LLC increased its holdings in shares of Grail by 273.0% during the 1st quarter. Signaturefd LLC now owns 1,876 shares of the company's stock worth $48,000 after buying an additional 1,373 shares during the last quarter. Finally, FNY Investment Advisers LLC purchased a new position in shares of Grail in the 4th quarter worth $26,000.
Grail Company Profile
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
